Portfolio Update

RNS Number : 8904R

Intl. Biotechnology Trust PLC

26 September 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 August 2017

Net Assets	£252m
Net Assets per share	672p
Share price	624p
Total value of unquoted investments	£21m
Total number of portfolio companies	92
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Gilead	7.8
Celgene	7.7
Regeneron	6.5
Biogen	5.9
Vertex	4.5
Alexion	4.0
Incyte	3.3
Shire	3.2
Biomarin	3.0
Genmab	3.0
	-----------
Total	48.9

Geographical Allocation	% NAV
US & Canada	85
Europe & UK	15
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	92
Unquoted	8
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	51
Mid Cap =USD1-10BN	25
Small Cap <USD1BN	24
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	33
Rare diseases	14
CNS	12
Infectious Diseases	11
Ophthalmology	8
Inflammation	7
Metabolic	5
Medtech	2
Other	8
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

26 SEPTEMBER 2017

 

END

 

 

PFUBLGDCBBDBGRL